MarginsXMarginsX
Home › Markets › Health Care › AORT

Artivion Inc. (AORT)

AORT trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$18.47
-3.30% on the day
Market cap
$901.1M
Small cap
Revenue · 2025
$441.3M
+13.6% on 2024
Net income · 2025
$9.8M
2.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/784199/000162828026009046/0001628280-26-009046-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAORT on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000784199
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$441.3M
Net income$9.8M
Operating income$33.7M
Net margin2.2%
Operating margin7.6%
Revenue growth+13.6%
Cash$64.9M
Total assets$884.8M
P/E (computed)92.3×
P/S (computed)2.0×

Warning signs

Cash runway
Cash-flow positive
$48.4M cash at September 30, 2026
Share count, 1 year
+3.0%
2025-10-31 to 2026-10-30 · +18.9% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$20.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$48.4M cash; operating cash flow $3.7M a quarter.Report 2026-09-30
Shares outstanding48,789,772 (2026-10-30); 47,374,939 a year earlier; 41,048,608 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Atlanta, Georgia, United StatesPCAOB Form AP 2026-03-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $20.4M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$123.8M-$7.9M-$4.6M$48.4M$363.8M$481.9M10-Q 2026-11-06
Q2 2026
2026-06-30
$125.8M-$13.5M-$1.3M$77.3M$363.4M$471.5M10-Q 2026-08-07
Q1 2026
2026-03-31
$116.3M$1.4M$1.2M$55.8M$215.4M$458.7M10-Q 2026-05-08
Q4 2025
2025-12-31
$116.0M$2.4M$19.6M$64.9M$215.1M$441.3M10-K 2026-02-18
Q3 2025
2025-09-30
$113.4M$6.5M$22.3M$73.4M$214.9M$422.6M10-Q 2026-11-06
Q2 2025
2025-06-30
$113.0M$1.3M$15.0M$53.5M$215.6M$405.0M10-Q 2026-08-07
Q1 2025
2025-03-31
$99.0M-$505K-$17.0M$37.7M$314.7M$390.1M10-Q 2026-05-08
Q4 2024
2024-12-31
$97.3M-$16.5M$10.1M$53.5M$314.3M$388.5M10-K 2026-02-18

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3ASR
S-3ASR2024-03-01
Latest annual report10-K2026-02-18
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-05
Latest proxy
ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEFA14A2026-04-01

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.5%
1 month-10.6%
3 months-32.8%
Year to date-58.1%
1 year-58.1%
From 52-week high-59.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BVSBioventus Inc.$10.46-1.88%$881.4M
BBNXBeta Bionics Inc.$15.21-7.37%$826.9M
KIDSOrthoPediatrics Corp.$31.50-2.63%$822.5M
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier